These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 31003835)
1. Emergence of ST147 Klebsiella pneumoniae carrying bla Shankar C; Kumar S; Venkatesan M; Veeraraghavan B J Infect Public Health; 2019; 12(5):741-743. PubMed ID: 31003835 [TBL] [Abstract][Full Text] [Related]
2. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia. Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087 [TBL] [Abstract][Full Text] [Related]
3. From Turkey: First Report of KPC-3- and CTX-M-27-Producing Multidrug-Resistant Özad Düzgün A Microb Drug Resist; 2021 Sep; 27(9):1265-1270. PubMed ID: 33794115 [No Abstract] [Full Text] [Related]
4. Role of association of OmpK35 and OmpK36 alteration and bla Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592 [TBL] [Abstract][Full Text] [Related]
5. Characterization of multidrug-resistant Klebsiella pneumoniae from Australia carrying blaNDM-1. Shoma S; Kamruzzaman M; Ginn AN; Iredell JR; Partridge SR Diagn Microbiol Infect Dis; 2014 Jan; 78(1):93-7. PubMed ID: 24157059 [TBL] [Abstract][Full Text] [Related]
6. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases. Joshi P; Shrivastava R; Bhagwat S; Patel M Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307 [TBL] [Abstract][Full Text] [Related]
7. Mutation of Dulyayangkul P; Wan Nur Ismah WAK; Douglas EJA; Avison MB Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312773 [TBL] [Abstract][Full Text] [Related]
8. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases. Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684 [TBL] [Abstract][Full Text] [Related]
9. Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece. Protonotariou E; Poulou A; Politi L; Sgouropoulos I; Metallidis S; Kachrimanidou M; Pournaras S; Tsakris A; Skoura L Int J Antimicrob Agents; 2018 Sep; 52(3):331-337. PubMed ID: 29654892 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation for clonality and transmission dynamics of an outbreak of Shankar C; Kumar M; Baskaran A; Paul MM; Ponmudi N; Santhanam S; Michael JS; Veeraraghavan B Indian J Med Microbiol; 2018; 36(1):54-60. PubMed ID: 29735827 [TBL] [Abstract][Full Text] [Related]
11. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt. Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596 [TBL] [Abstract][Full Text] [Related]
12. Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3. Humphries RM; Hemarajata P Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396547 [No Abstract] [Full Text] [Related]
13. Characterization of the Genetic Background of KPC-2-Producing Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046 [TBL] [Abstract][Full Text] [Related]